Eiger BioPharmaceuticals
Why Robinhood?
You can watch EIGR and buy or sell other stocks, ETFs, and their options commission-free!About EIGR
Eiger BioPharmaceuticals, Inc. operates as a biopharmaceutical company, which focuses on the development of innovative therapies for rare metabolic diseases. It is also developing avexitide as a treatment for Post-Bariatric Hypoglycemia.
EIGR Key Statistics
Stock Snapshot
With a market cap of 12.59M, Eiger BioPharmaceuticals(EIGR) trades at $8.50. The stock has a price-to-earnings ratio of -0.17.
On 2026-04-01, Eiger BioPharmaceuticals(EIGR) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Eiger BioPharmaceuticals(EIGR) stock has reached 0, versus its average volume of 507.4.
Over the past 52 weeks, Eiger BioPharmaceuticals(EIGR) stock has traded between a high of $16.00 and a low of $1.10.
Over the past 52 weeks, Eiger BioPharmaceuticals(EIGR) stock has traded between a high of $16.00 and a low of $1.10.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.